Authors
Dean Cutajar, University of WollongongFollow
Michael L. Lerch, University of WollongongFollow
George J. Takacs, University of WollongongFollow
Bong Soo Lee, Konkuk University
Y Chin, St George Cancer Care Centre, Kogarah, Australia
J Bucci, St George Cancer Care Centre, Kogarah, Australia
M Zaider, Memorial Sloan Kettering Cancer Center, New York, USA
M Zelefsky, Memorial Sloan Kettering Cancer Center, New York, USA
J. Yamada, Memorial Sloan Kettering Cancer Center, New York, USA
Gil'ad Cohen, Memorial Sloan Kettering Cancer Center, New York, USA
V L Perevertaylo, SPA BIT, Ukraine
Anatoly B. Rosenfeld, University of WollongongFollow
Abstract
We have developed a urethral dosimetry system for real time dose verification along the urethra during permanent implant prostate brachytherapy. The urethral alarm probe uses “spectroscopic dosimetry” to calculate the dose rate along the urethra in real time. The application of spectroscopic dosimetry for the urethral alarm probe was verified using Monte Carlo calculations. In phantom depth dose measurements as well as isotropy measurements were performed to verify the usefulness of the urethra alarm probe as an in vivo real time dosimeter.
Publication Details
Cutajar, D, Lerch, MLF, Takacs, GJ, Lee, B, Chin, Y, Bucci, J, Zaider, M, Zelefsky, M, Yamada, J, Cohen, G, Perevertaylo, V & Rosenfeld, AB, Urethral alarm probe for permanent prostate implants, Journal of Nuclear Science and Technology, S5, 2008, 455-457.